Why EU Expansion Can Trigger a Supplement Formula Review

One of the most common assumptions made by supplement brands is that the European Union is one completely harmonised market. Create one formula. Prepare one label.

Translate it into several languages. Then start selling across Europe. In practice, it is rarely that simple.

There are common EU rules covering important areas such as permitted vitamin and mineral sources, labelling and claims. However, maximum and minimum amounts of vitamins and minerals have not been fully harmonised across the EU. That creates a difficult position for growing brands. A supplement accepted in one country may need further assessment before it is launched in another.

Sometimes the label needs changing. Sometimes the recommended daily intake needs reviewing. Sometimes the formulation itself becomes the issue.

Key takeaway: Choose the intended markets before finalising the formula, daily dose, claims and packaging.

Who Does This Apply To?

This is particularly relevant to:

• UK Supplement Brands Entering the EU: Businesses that have developed products primarily for the British market.
• US and International Brands: Products designed around non-European serving sizes and marketing language often need significant review.
• EU Brands Expanding Between Member States: Being established in one EU country does not remove every market-specific consideration.
• Private-Label Supplement Businesses: A manufacturer may describe a formulation as “EU compliant” without assessing every intended country.
• Importers and Distributors: The local business may be the first to discover that a product does not fit the expectations of its target market.
• Brands Selling High-Strength Products: Higher-dose products naturally attract closer attention when national approaches differ.

This is not only relevant to multivitamins. Single-nutrient products, powders, liquids, gummies, sprays and combination supplements can all require review.

What Does This Mean in Practice?

EU food-supplement law establishes a shared framework. It includes rules around which vitamins and minerals may be used and which chemical forms are permitted. The legislation also envisages harmonised maximum and minimum amounts.

The difficulty is that EU-wide maximum amounts have not yet been adopted. This means supplement businesses may need to consider the approach taken within each intended market. One country may apply legislation, guidance or risk-management approaches that differ from another.

Notification procedures can also vary. That does not mean every product requires reformulation. It does mean that “sold somewhere in the EU” should not be treated as proof that the same formula can be launched everywhere without further assessment.

Scientific Limits and Legal Limits Are Not the Same Thing

EFSA publishes scientific assessments, including tolerable upper intake levels for nutrients. These are important when assessing safety. However, a scientific upper intake level should not automatically be treated as the legal maximum dose for every supplement product.

The assessment may consider total intake from all dietary sources, different age groups and areas of uncertainty. Regulatory decisions can also take account of other factors. This distinction matters when a supplier says:

“The dose is below the EFSA upper limit, so it is compliant.”

That may be relevant evidence. It is not always the end of the assessment.

Common Mistakes Businesses Make

1. Treating the EU as One Supplement Market

The EU provides a substantial shared framework, but national differences remain. A market-entry plan should identify the intended countries before the label and production run are finalised.

2. Starting With Translation

Translating an existing label does not make the underlying product suitable for the new market. The formula, daily dose, warnings, ingredient names and claims should be reviewed first. Otherwise, the brand simply creates several translated versions of the same compliance problem.

3. Relying Entirely on the Contract Manufacturer

A manufacturer may supply an established stock formula. That does not necessarily mean it has been assessed against every country where the brand intends to sell it. Ask what “EU compliant” actually covers.

Which markets? Which daily dose? Which label?

Which claims?

4. Looking Only at the Ingredient Quantity

The amount of a nutrient is important, but it is not the only issue. The review may also need to consider:

• The permitted nutrient source
• The recommended daily intake
• Consumer age group
• Warnings
• Combination with other nutrients
• Nutrition and health claims
• Label declarations
• Measurement tolerances
• National notification requirements

A formula cannot be separated from the way it is presented and used.

5. Printing Packaging Before Choosing the Markets

This happens more often than it should. A brand prints a large multilingual packaging run and then begins assessing individual countries. Any required changes become far more expensive once thousands of units have been produced.

Your EU Supplement Expansion Checklist

• Target Countries: Have you identified the actual EU countries where the product will be sold?
• Product Category: Is the product clearly positioned as a food supplement rather than a medicine or another regulated product?
• Nutrient Sources: Are all vitamin and mineral forms permitted for the intended use?
• Daily Dose: Has the recommended daily intake been assessed for each market?
• Safety Evidence: Does the assessment consider relevant scientific guidance and total exposure?
• National Position: Have country-specific maximum-level approaches or guidance been reviewed?
• Warnings: Are any market-specific warnings or restrictions relevant?
• Claims: Are all nutrition and health claims authorised and used under the correct conditions?
• Label Language: Is the mandatory information provided in the required language or languages?
• Notification: Does the target country require pre-market or market notification?
• Responsible Business: Is it clear which food business operator is responsible for the product?
• Change Planning: If the formula needs adjusting, have claims, nutrition values and stability implications also been considered?

The earlier these questions are asked, the more commercially useful the answers become.

How Conformity Services Can Help

Conformity Services supports supplement manufacturers, importers and growing brands entering the UK and European markets. Our work can include:

• Supplement formula reviews
• Vitamin and mineral source assessments
• Market-specific compliance gap analysis
• Ingredient and supplier-document reviews
• Novel-food screening
• Label and artwork reviews
• Nutrition and health-claim assessments
• UK Food Business Operator support
• EU market-entry planning
• Ongoing outsourced supplement compliance

We do not begin by assuming that a reformulation is necessary. The first step is understanding the existing product, intended consumer, daily dose and target markets. From there, the business can decide whether it needs a label change, additional evidence, a different launch strategy or a revised formulation.

Final Thoughts

The EU may be a single market, but supplement compliance is not completely identical in every Member State. That is why market selection should be part of product development rather than something decided after manufacturing. A formula that works well in one country may still be suitable elsewhere.

It simply needs to be assessed rather than assumed. That assessment is usually much easier before the packaging has been printed and the first shipment is already moving.

Sources and official guidance

This article provides general information, not legal advice. Supplement requirements and notification practices can vary by Member State and should be checked for each target market.

• European Commission: food supplements and Directive 2002/46/EC
• European Commission: nutrition and health claims
• European Commission: novel food guidance and catalogue